Pregnancy outcomes in patients with systemic autoimmunity

References

• Marker-Hermann E, Fischer-Betz R. Rheumatic diseases and pregnancy. Curr Opin Obstet Gynecol. 2010; 22 6: 458–465.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005; 52 2: 514–521.
   PubMed Web of Science ®Google Scholar
• Wei Q, Ouyang Y, Zeng W, Duan L, Ge J, Liao H. Pregnancy complicating systemic lupus erythematosus: A series of 86 cases. Arch Gynecol Obstet. 2010; Dec 7.
   Google Scholar
• Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus. 2004; 13 9: 688–689.
   PubMed Web of Science ®Google Scholar
• Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of autoimmunity and pregnancy. J Autoimmun. 2010; 34 3: 287–299.
   PubMed Web of Science ®Google Scholar
• Mecacci F, Pieralli A, Bianchi B, Paidas MJ. The impact of autoimmune disorders and adverse pregnancy outcome. Semin Perinatol. 2007; 31 4: 223–226.
   PubMed Web of Science ®Google Scholar
• Witter FR. Management of the high-risk lupus pregnant patient. Rheum Dis Clin North Am. 2007; 33 2: 253–265.
   PubMed Web of Science ®Google Scholar
• Sammaritano LR. Antiphospholipid syndrome: Review. South Med J. 2005; 98 6: 617–625.
   PubMed Web of Science ®Google Scholar
• Pasquali JL, Poindron V, Korganow AS, Martin T. The antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2008; 22 5: 831–845.
   PubMed Web of Science ®Google Scholar
• Boffa MC, Boinot C, De Carolis S, Rovere-Querini P, Aurousseau MH, Allegri F, . Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost. 2009; 102 1: 25–28.
   PubMed Web of Science ®Google Scholar
• Ambrosio P, Lermann R, Cordeiro A, Borges A, Nogueira I, Serrano F. Lupus and pregnancy – 15 years of experience in a tertiary center. Clin Rev Allergy Immunol. 2010; 38 2–3: 77–81.
   PubMed Web of Science ®Google Scholar
• Tincani A, Branch W, Levy RA, Piette JC, Carp H, Rai RS, . Treatment of pregnant patients with antiphospholipid syndrome. Lupus. 2003; 12 7: 524–529.
   PubMed Web of Science ®Google Scholar
• Mak A, Cheung MW, Cheak AA, Ho RC. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: A meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford). 2010; 49 2: 281–288.
   PubMed Web of Science ®Google Scholar
• Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol. 2011; 40 1: 27–41.
   PubMed Web of Science ®Google Scholar
• Steen VD. Pregnancy in scleroderma. Rheum Dis Clin North Am. 2007; 33 2: 345–358.
   PubMed Web of Science ®Google Scholar
• Ticconi C, Rotondi F, Veglia M, Pietropolli A, Bernardini S, Ria F, . Antinuclear autoantibodies in women with recurrent pregnancy loss. Am J Reprod Immunol. 2010; 64 6: 384–392.
   PubMed Web of Science ®Google Scholar
• Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, . International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum. 1999; 42 7: 1309–1311.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4 2: 295–306.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002; 78 2: 179–190.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: A population-based prospective study. Fertil Steril. 2003; 79 3: 577–584.
   PubMed Web of Science ®Google Scholar
• Kaandorp S, di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev. 2009; 21 1 Art:No:CD004734.
   Google Scholar
• Reddy UM. Management of pregnancy after stillbirth. Clin Obstet Gynecol. 2010; 53 3: 700–709.
   PubMed Web of Science ®Google Scholar
• Chauleur C, Galanaud JP, Alonso S, Cochery-Nouvellon E, Balducchi JP, Mares P, . Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. J Thromb Haemost. 2010; 8 4: 699–706.
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Favaro M, Tonello M, Visentin MS, deCarolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A. Risk factors for pregnancy failure in patients with antiphospholipid syndrome treated with conventional therapies. A multicentre case-control study. Rheumatology. 2011 In press.
   PubMed Web of Science ®Google Scholar
• James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv. 2008; 63 1: 49–57.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Ozaki Y, Nakanishi T, Sato T, Suzumori N, Kumagai K. Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: A retrospective cohort-control study. Am J Reprod Immunol. 2008; 59 3: 235–241.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Martinez-Berriotxoa A, Egurbide MV. The antiphospholipid syndrome in the 21st century. Med Clin. 2009; 133 10: 390–396.
   PubMed Web of Science ®Google Scholar
• Tuthill JI, Khamashta MA. Management of antiphospholipid syndrome. J Autoimmun. 2009; 33 2: 92–98.
   PubMed Web of Science ®Google Scholar
• Bramham K, Hunt BJ, Germain S, Calatayud I, Khamashta M, Bewley S, . Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus. 2010; 19 1: 58–64.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Bazzani C, Taraborelli M, Reggia R, Lojacono A, Brucato A, . Pregnancy in autoimmune rheumatic diseases: The importance of counselling for old and new challenges. Autoimmun Rev. 2010; 10 1: 51–54.
   PubMed Web of Science ®Google Scholar
• Hossain N, Schatz F, Paidas MJ. Heparin and maternal fetal interface: Why should it work to prevent pregnancy complications?. Thromb Res. 2009; 124 6: 653–655.
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: Implications for vascular inflammation and thrombosis. Mol Immunol. 2010; 47 13: 2170–2175.
   PubMed Web of Science ®Google Scholar
• Laskin CA, Clark CA, Spitzer KA. Antiphospholipid syndrome in systemic lupus erythematosus: Is the whole greater than the sum of its parts?. Rheum Dis Clin North Am. 2005; 31 2: 255–272.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: Integrating clues from the bench and bedside. Eur J Clin Invest. 2011; 41 6: 672–678.
   PubMed Web of Science ®Google Scholar
• Gaipl US, Beyer TD, Baumann I, Voll RE, Stach CM, Heyder P, . Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal implications for antiphospholipid syndrome and systemic lupus erythematosus. Immunobiology. 2003; 207 1: 73–81.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010; 6 5: 280–289.
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P, Castiglioni MT, Sabbadini MG, Manfredi AA. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity. 2007; 40 4: 290–294.
   PubMed Web of Science ®Google Scholar
• Munoz LE, Lauber K, Schiller M, Manfredi AA, Schett G, Voll RE, . The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE. Z Rheumatol. 2010; 69 2 152, 154–156.
   PubMed Web of Science ®Google Scholar